0001437749-14-005260 Sample Contracts

Dated 21st October 2002 OXFORD IMMUNOTEC GLOBAL PLC (1) and DR P WRIGHTON-SMITH (2) SERVICE AGREEMENT
Service Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
AutoNDA by SimpleDocs
REGISTRATION RIGHTS AGREEMENT dated 21 November, 2013 by and among Oxford Immunotec Global PLC and certain shareholders
Registration Rights Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
SECOND AMENDMENT TO SUPPLY AGREEMENT
Supply Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances

THIS SECOND AMENDMENT TO SUPPLY AGREEMENT (“Second Amendment”) is made and entered into as of the 25 day of March 2014 (“Effective Date”) by and between EMD Millipore Corporation, (“Millipore”) and Oxford Immunotec, Ltd. (“Oxford”).

Contract
Oxford Immunotec Global PLC • March 27th, 2014 • In vitro & in vivo diagnostic substances • California

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS, AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 4 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

Contract
Oxford Immunotec Global PLC • March 27th, 2014 • In vitro & in vivo diagnostic substances • England and Wales

THIS WARRANT AND THE SHARES PURCHASABLE HEREUNDER HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN EXEMPTION THEREFROM UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

Dated and Assignment
Agreement • March 27th, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
Time is Money Join Law Insider Premium to draft better contracts faster.